Who Buys Spironolactone from India — 471 Importers Behind a $197.4M Market
India's spironolactone import market is served by 471 active buyers who collectively imported $197.4M across 5,262 shipments. EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) leads with a 57.0% market share, followed by AMNEAL PHARMACEUTICALS, LLC (KY) and AMNEAL PHARMACEUTICALS LLC KY. The top 5 buyers together control 77.9% of total import value, reflecting a concentrated buyer landscape.
Top Spironolactone Importers — Ranked by Import Value
EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) is the leading spironolactone importer from India, holding a 57.0% share of the $197.4M market across 5,262 shipments from 471 buyers. The top 5 buyers — EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), AMNEAL PHARMACEUTICALS, LLC (KY) (UNITED STATES), AMNEAL PHARMACEUTICALS LLC KY (UNITED STATES), AUROLOGISTICS LLC (AUROBINDO PHARMA (UNITED STATES), NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES) — collectively control 77.9% of total import value.
Top Spironolactone Buyers & Importers
Ranked by import value · 471 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCE SERVICESUNITED STATES SPIRONOLACTONE TABLETS 50MG 1X500 PACKS)SPIRONOLACTONE TABLETS 50MG 1X100 PACKS) | $112.6M | 5 | 57.0% |
| 2 | AMNEAL PHARMACEUTICALS, LLC (KY)UNITED STATES SPIRONOLACTONE TABLETS 50MG 1X500 PACKS)SPIRONOLACTONE TABLETS 50MG 1X100 PACKS) | $22.7M | 5 | 11.5% |
| 3 | AMNEAL PHARMACEUTICALS LLC KYUNITED STATES SPIRONOLACTONE TABLETS 50MG 1X500 PACKS)SPIRONOLACTONE TABLETS 50MG 1X100 PACKS) | $9.0M | 5 | 4.5% |
| 4 | AUROLOGISTICS LLC (AUROBINDO PHARMAUNITED STATES SPIRONOLACTONE TABLETS 50MG 1X500 PACKS)SPIRONOLACTONE TABLETS 50MG 1X100 PACKS) | $5.3M | 5 | 2.7% |
| 5 | NORTHSTAR DISTRIBUTION CENTER 8912UNITED STATES SPIRONOLACTONE TABLETS 50MG 1X500 PACKS)SPIRONOLACTONE TABLETS 50MG 1X100 PACKS) | $4.2M | 5 | 2.1% |
| 6 | BROCACEF NL : HUBNETHERLANDS PHARMA DRUGS & MEDI SPIRONOLACTONE 50MG1PHARMA DRUGS & MEDI SPIRONOLACTONE 25MG1 | $3.8M | 5 | 1.9% |
| 7 | AMNEAL PHARMACEUTICALS LLCUNITED STATES SPIRONOLACTONE TABLETS 50MG 1X500 PACKS)SPIRONOLACTONE TABLETS 50MG 1X100 PACKS) | $3.7M | 5 | 1.9% |
| 8 | AUROLOGISTICS LLC AUROBINDO PHARMUNITED STATES SPIRONOLACTONE TABLETS 50MG 1X500 PACKS)SPIRONOLACTONE TABLETS 50MG 1X100 PACKS) | $3.1M | 5 | 1.6% |
| 9 | AMNEAL PHARMACEUTICALS LLC (KY)UNITED STATES SPIRONOLACTONE TABLETS 50MG 1X500 PACKS)SPIRONOLACTONE TABLETS 50MG 1X100 PACKS) | $3.1M | 5 | 1.5% |
| 10 | AUROLOGISTICS LLC, (AUROBINDO PHARMUNITED STATES SPIRONOLACTONE TABLETS 50MG 1X500 PACKS)SPIRONOLACTONE TABLETS 50MG 1X100 PACKS) | $2.5M | 5 | 1.3% |
| 11 | BROCACEF NL:EU HUBNETHERLANDS PHARMA DRUGS & MEDI SPIRONOLACTONE 50MG1PHARMA DRUGS & MEDI SPIRONOLACTONE 25MG1 | $1.6M | 5 | 0.8% |
| 12 | AUROLOGISTICS LLCUNITED STATES SPIRONOLACTONE TABLETS 50MG 1X500 PACKS)SPIRONOLACTONE TABLETS 50MG 1X100 PACKS) | $1.5M | 5 | 0.8% |
| 13 | MINT PHARMACEUTICALS INCCANADA SPIRONOLACTONE TABLETS 50MG 1X500 PACKS)SPIRONOLACTONE TABLETS 50MG 1X100 PACKS)SPIRONOLACTONE TABLETS USP 25MG | $1.4M | 5 | 0.7% |
| 14 | LEXON UK LIMITEDUNITED KINGDOM SPIRONOLACTONE 100 MG TABLETS 2X14`SSPIRONOLACTONE 100 MG TABLETSSPIRONOLACTONE 50MG TABS PVCBL 2X14S | $1.4M | 5 | 0.7% |
| 15 | AUROLOGISTICS LLC(AUROBINDO PHARMAUNITED STATES SPIRONOLACTONE TABLETS 50MG 1X500 PACKS)SPIRONOLACTONE TABLETS 50MG 1X100 PACKS) | $1.4M | 5 | 0.7% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Spironolactone — and from which countries?
Flow of Spironolactone exports from India: each country's share and the named importers behind the numbers
Spironolactone — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $172.2M through 929 shipments. This represents a market share of 87.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• EVERSANA LIFE SCIENCE SERVICES - $112.6M (65.4% of country's total business)
• AMNEAL PHARMACEUTICALS, LLC (KY) - $22.7M (13.2% of country's total business)
• AMNEAL PHARMACEUTICALS LLC KY - $9.0M (5.2% of country's total business)
• AUROLOGISTICS LLC (AUROBINDO PHARMA - $5.3M (3.1% of country's total business)
• NORTHSTAR DISTRIBUTION CENTER 8912 - $4.2M (2.4% of country's total business)
• Rest of United States's importers - $18.4M (10.7% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $185.3K, indicating premium pricing strategy compared to the market average of $37.5K.
United States is a key market for Spironolactone imports, representing 87.2% of total trade value.
2Netherlands
Netherlands emerges as the second largest importing country, achieving a total trade value of $11.9M through 307 shipments. This represents a market share of 6.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Netherlands has a diverse importer base, with their top importers including:
• BROCACEF NL : HUB - $3.8M (32.1% of country's total business)
• BROCACEF NL:EU HUB - $1.6M (13.6% of country's total business)
• BROCACEF NL HUB - $1.2M (9.9% of country's total business)
Key Insight: Netherlands demonstrates strong market positioning with an average shipment value of $38.8K, indicating premium pricing strategy compared to the market average of $37.5K.
Netherlands is a key market for Spironolactone imports, representing 6.0% of total trade value.
3United Kingdom
United Kingdom emerges as the third largest importing country, achieving a total trade value of $2.1M through 26 shipments. This represents a market share of 1.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United Kingdom has a diverse importer base, with their top importers including:
• LEXON UK LIMITED - $1.4M (63.4% of country's total business)
Key Insight: United Kingdom demonstrates strong market positioning with an average shipment value of $82.1K, indicating premium pricing strategy compared to the market average of $37.5K.
United Kingdom is a key market for Spironolactone imports, representing 1.1% of total trade value.
4Canada
Canada emerges as the fourth largest importing country, achieving a total trade value of $2.0M through 27 shipments. This represents a market share of 1.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• MINT PHARMACEUTICALS INC - $1.4M (71.9% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $74.2K, indicating premium pricing strategy compared to the market average of $37.5K.
Canada is a key market for Spironolactone imports, representing 1.0% of total trade value.
5Kenya
Kenya emerges as the fifth largest importing country, achieving a total trade value of $1.4M through 0 shipments. This represents a market share of 0.7% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Kenya demonstrates strong market positioning with an average shipment value of $1.4M, indicating premium pricing strategy compared to the market average of $37.5K.
Kenya is a key market for Spironolactone imports, representing 0.7% of total trade value.
Buyer Segment Analysis
TransData Nexus Spironolactone buyer market intelligence
1Buyer Segment Analysis
The importation of Spironolactone from India involves various buyer segments, each with distinct purchasing behaviors and order patterns.
Distributors: Entities like EVERSANA LIFE SCIENCE SERVICES and AMNEAL PHARMACEUTICALS, LLC (KY) in the United States function as distributors. They procure large volumes to supply to pharmacies, hospitals, and healthcare providers. Their purchasing patterns are characterized by bulk orders to maintain consistent supply chains and meet market demand.
Contract Manufacturers: Companies such as AUROLOGISTICS LLC (AUROBINDO PHARMA) in the United States act as contract manufacturers. They import Spironolactone for formulation and packaging under various brand names. Their procurement is aligned with production schedules and market demand forecasts, leading to periodic large-scale orders.
Re-exporters: Entities like BROCACEF NL : HUB in the Netherlands may serve as re-exporters. They import Spironolactone for distribution to other European markets, leveraging strategic geographic positioning. Their purchasing behavior involves substantial orders to fulfill regional demand and regulatory requirements.
Country-Specific Import Regulations
TransData Nexus Spironolactone buyer market intelligence
1Country-Specific Import Regulations
United States:
Netherlands:
United Kingdom:
Canada:
Kenya:
Demand Drivers & Market Opportunity
TransData Nexus Spironolactone buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Spironolactone in importing countries is driven by several factors:
Disease Prevalence: Spironolactone is primarily used to treat conditions such as hypertension, heart failure, and edema. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for approximately 17.9 million deaths annually as of 2023. The high prevalence of these conditions necessitates a steady demand for effective treatments like Spironolactone.
Government Healthcare Programs and Universal Health Coverage Expansion: Many countries are expanding their healthcare programs to achieve universal health coverage. For instance, Kenya's Universal Health Coverage (UHC) pilot program, launched in 2018, aims to provide affordable healthcare to all citizens. Such initiatives increase access to essential medicines, boosting demand for drugs like Spironolactone.
WHO Essential Medicines List Procurement and Tender-Based Purchasing: Spironolactone is listed on the WHO Model List of Essential Medicines, indicating its importance in a basic health system. This inclusion encourages governments and international organizations to procure it through tender-based purchasing, ensuring availability and affordability. The presence of 471 buyers across 112 countries, as per TransData Nexus data, underscores the global reach and demand for Spironolactone.
Common Questions — Spironolactone Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest spironolactone buyer importing from India?
Based on import volume and value, EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) leads with $112.6M in imports and a 57.0% market share — the highest of any single spironolactone importer. AMNEAL PHARMACEUTICALS, LLC (KY) (UNITED STATES) and AMNEAL PHARMACEUTICALS LLC KY (UNITED STATES) are the next largest buyers.
QHow many companies buy spironolactone from India?
There are 471 active spironolactone buyers importing from India, with a combined market of $197.4M across 5,262 shipments to 112 countries. The top 5 buyers hold 77.9% of total import value, while the remaining 466 buyers handle the other 22.1%.
QWhich countries import the most spironolactone from India?
The top importing countries for spironolactone from India are United States (87.2%), Netherlands (6.0%), United Kingdom (1.1%), Canada (1.0%), Kenya (0.7%). These markets represent the largest demand centres for Indian pharmaceutical exports of spironolactone, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for spironolactone from India?
The average import transaction value for spironolactone from India is $37.5K, with an average unit price of $7.21 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Spironolactone buyer market intelligence
1Buyer Segment Analysis
The importation of Spironolactone from India involves various buyer segments, each with distinct purchasing behaviors and order patterns.
Distributors: Entities like EVERSANA LIFE SCIENCE SERVICES and AMNEAL PHARMACEUTICALS, LLC (KY) in the United States function as distributors. They procure large volumes to supply to pharmacies, hospitals, and healthcare providers. Their purchasing patterns are characterized by bulk orders to maintain consistent supply chains and meet market demand.
Contract Manufacturers: Companies such as AUROLOGISTICS LLC (AUROBINDO PHARMA) in the United States act as contract manufacturers. They import Spironolactone for formulation and packaging under various brand names. Their procurement is aligned with production schedules and market demand forecasts, leading to periodic large-scale orders.
Re-exporters: Entities like BROCACEF NL : HUB in the Netherlands may serve as re-exporters. They import Spironolactone for distribution to other European markets, leveraging strategic geographic positioning. Their purchasing behavior involves substantial orders to fulfill regional demand and regulatory requirements.
Country-Specific Import Regulations
TransData Nexus Spironolactone buyer market intelligence
1Country-Specific Import Regulations
United States:
Netherlands:
United Kingdom:
Canada:
Kenya:
Demand Drivers & Market Opportunity
TransData Nexus Spironolactone buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Spironolactone in importing countries is driven by several factors:
Disease Prevalence: Spironolactone is primarily used to treat conditions such as hypertension, heart failure, and edema. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for approximately 17.9 million deaths annually as of 2023. The high prevalence of these conditions necessitates a steady demand for effective treatments like Spironolactone.
Government Healthcare Programs and Universal Health Coverage Expansion: Many countries are expanding their healthcare programs to achieve universal health coverage. For instance, Kenya's Universal Health Coverage (UHC) pilot program, launched in 2018, aims to provide affordable healthcare to all citizens. Such initiatives increase access to essential medicines, boosting demand for drugs like Spironolactone.
WHO Essential Medicines List Procurement and Tender-Based Purchasing: Spironolactone is listed on the WHO Model List of Essential Medicines, indicating its importance in a basic health system. This inclusion encourages governments and international organizations to procure it through tender-based purchasing, ensuring availability and affordability. The presence of 471 buyers across 112 countries, as per TransData Nexus data, underscores the global reach and demand for Spironolactone.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 471 global importers of Spironolactone identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 5,262 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 112 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5,262 Verified Shipments
471 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists